Canada Supreme Court to Hear Challenge to Pfizer’s Viagra Patent by Teva Canada

The Supreme Court of Canada has announced that it would hear Teva Canada Ltd.’s challenge to Pfizer Inc.’s patent for Viagra. The high court granted Teva Canada’s leave to appeal without comment Thursday, agreeing to review a September 2010 ruling from Canada’s Federal Court of Appeal that barred Teva Canada from producing a generic version of the drug prior to Teva Canada could not produce a generic version of Viagra until Pfizer’s Canadian patent expiring.



Categories: drugs, Intellectual Property, Patents, pharmaceuticals, pharmaceuticals and Biotechnology, Teva

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: